Antimicrobial peptides with cell-penetrating activity as prophylactic and treatment drugs

Author:

del Rio Gabriel1ORCID,Trejo Perez Mario A.1,Brizuela Carlos A.2

Affiliation:

1. 1Department of Biochemistry and Structural Biology, Instituto de Fisiologia Celular, UNAM, Mexico City 04510, Mexico

2. 2Department of Computer Science, CICESE Research Center, Ensenada 22860, Mexico

Abstract

Abstract Health is fundamental for the development of individuals and evolution of species. In that sense, for human societies is relevant to understand how the human body has developed molecular strategies to maintain health. In the present review, we summarize diverse evidence that support the role of peptides in this endeavor. Of particular interest to the present review are antimicrobial peptides (AMP) and cell-penetrating peptides (CPP). Different experimental evidence indicates that AMP/CPP are able to regulate autophagy, which in turn regulates the immune system response. AMP also assists in the establishment of the microbiota, which in turn is critical for different behavioral and health aspects of humans. Thus, AMP and CPP are multifunctional peptides that regulate two aspects of our bodies that are fundamental to our health: autophagy and microbiota. While it is now clear the multifunctional nature of these peptides, we are still in the early stages of the development of computational strategies aimed to assist experimentalists in identifying selective multifunctional AMP/CPP to control nonhealthy conditions. For instance, both AMP and CPP are computationally characterized as amphipatic and cationic, yet none of these features are relevant to differentiate these peptides from non-AMP or non-CPP. The present review aims to highlight current knowledge that may facilitate the development of AMP’s design tools for preventing or treating illness.

Publisher

Portland Press Ltd.

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference151 articles.

1. An antisense oligonucleotide splicing modulator to treat spinal muscular atrophy;Chen;Nat. Res.,2019

2. Peptide therapeutics: current status and future directions;Fosgerau;Drug Discov. Today,2015

3. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge;Scott;Nat. Rev. Drug Discov.,2016

4. In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeutics;Villoutreix;Curr. Pharm. Biotechnol.,2008

5. Antibacterial peptides for therapeutic use: obstacles and realistic outlook;Marr;Curr. Opin. Pharmacol.,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3